These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 3731084
1. Abnormally banded chromosomal regions in doxorubicin-resistant B16-BL6 murine melanoma cells. Slovak ML, Hoeltge GA, Ganapathi R. Cancer Res; 1986 Aug; 46(8):4171-7. PubMed ID: 3731084 [Abstract] [Full Text] [Related]
2. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells. Ganapathi R, Grabowski D, Schmidt H, Bell D, Melia M. Cancer Res; 1987 Jul 01; 47(13):3464-8. PubMed ID: 2884031 [Abstract] [Full Text] [Related]
9. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells. Tapiero H, Nguyen-Ba G, Lampidis TJ. Pathol Biol (Paris); 1994 Apr 01; 42(4):328-37. PubMed ID: 7808786 [Abstract] [Full Text] [Related]
10. Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cells. Biedler JL, Chang TD, Scotto KW, Melera PW, Spengler BA. Cancer Res; 1988 Jun 01; 48(11):3179-87. PubMed ID: 3365701 [Abstract] [Full Text] [Related]
11. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Ogretmen B, McCauley MD, Safa AR. Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006 [Abstract] [Full Text] [Related]
12. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB. Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205 [Abstract] [Full Text] [Related]
13. Spontaneous sister chromatid exchange in metastatic variants of the murine B16 melanoma and human astrocytomas in culture. Lakshmi MS, Hunt G, Sherbet GV. Invasion Metastasis; 1988 Nov 01; 8(4):205-16. PubMed ID: 3139579 [Abstract] [Full Text] [Related]
14. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole. Desai PB, Duan J, Sridhar R, Damle BD. Methods Find Exp Clin Pharmacol; 1997 May 01; 19(4):231-9. PubMed ID: 9228648 [Abstract] [Full Text] [Related]
15. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Dalton WS, Durie BG, Alberts DS, Gerlach JH, Cress AE. Cancer Res; 1986 Oct 01; 46(10):5125-30. PubMed ID: 2875788 [Abstract] [Full Text] [Related]
16. Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance. Ganapathi R, Schmidt H, Grabowski D, Melia M, Ratliff N. Br J Cancer; 1988 Sep 01; 58(3):335-40. PubMed ID: 3179186 [Abstract] [Full Text] [Related]
17. Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicin. Panneerselvam M, Bredehorst R, Vogel CW. Cancer Res; 1987 Sep 01; 47(17):4601-7. PubMed ID: 3621156 [Abstract] [Full Text] [Related]